ROMANO, Mario
 Distribuzione geografica
Continente #
NA - Nord America 5.412
EU - Europa 3.768
AS - Asia 3.576
SA - Sud America 342
AF - Africa 74
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 12
AN - Antartide 1
Totale 13.197
Nazione #
US - Stati Uniti d'America 5.279
SG - Singapore 1.416
CN - Cina 896
IT - Italia 727
IE - Irlanda 473
UA - Ucraina 456
GB - Regno Unito 412
SE - Svezia 394
RU - Federazione Russa 383
TR - Turchia 360
FR - Francia 321
VN - Vietnam 316
IN - India 273
BR - Brasile 259
DE - Germania 241
FI - Finlandia 129
CA - Canada 80
HK - Hong Kong 77
PL - Polonia 61
KR - Corea 44
AT - Austria 43
JP - Giappone 36
MX - Messico 36
BD - Bangladesh 31
AR - Argentina 30
NL - Olanda 29
ZA - Sudafrica 28
ES - Italia 24
PE - Perù 19
IQ - Iraq 18
EG - Egitto 17
BE - Belgio 16
PK - Pakistan 15
CZ - Repubblica Ceca 14
IR - Iran 13
EU - Europa 11
IL - Israele 11
PH - Filippine 11
KE - Kenya 10
UZ - Uzbekistan 10
AU - Australia 9
BZ - Belize 9
LT - Lituania 9
MA - Marocco 9
VE - Venezuela 8
CL - Cile 7
CO - Colombia 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
ID - Indonesia 6
PT - Portogallo 5
TW - Taiwan 5
PY - Paraguay 4
RO - Romania 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
EC - Ecuador 3
EE - Estonia 3
GE - Georgia 3
HR - Croazia 3
LB - Libano 3
MY - Malesia 3
OM - Oman 3
PA - Panama 3
RS - Serbia 3
SI - Slovenia 3
GR - Grecia 2
HU - Ungheria 2
JO - Giordania 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AQ - Antartide 1
BH - Bahrain 1
CH - Svizzera 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HN - Honduras 1
KI - Kiribati 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 13.197
Città #
Singapore 1.065
Chandler 666
San Jose 562
Jacksonville 517
Dublin 467
Ashburn 378
Dallas 282
Southend 268
Beijing 213
Princeton 207
Izmir 202
New York 165
Santa Clara 135
Nanjing 132
Los Angeles 126
Dearborn 112
The Dalles 110
Boardman 108
Chieti 102
Ho Chi Minh City 93
Altamura 90
Wilmington 88
Cambridge 80
Ann Arbor 73
Hanoi 73
Tongling 66
Nanchang 63
Hong Kong 61
Pescara 53
Rome 48
Buffalo 46
Moscow 45
Warsaw 45
Council Bluffs 43
Helsinki 37
Seoul 37
Montreal 36
Montesilvano 34
São Paulo 34
Vienna 34
Tokyo 33
Munich 30
San Mateo 29
Denver 27
Houston 27
Washington 26
Hebei 24
Toronto 24
Woodbridge 24
Brooklyn 23
Kunming 23
Orem 23
Redondo Beach 23
Tianjin 23
Dong Ket 22
Johannesburg 22
Shenyang 22
Düsseldorf 21
Jiaxing 21
Falls Church 20
Nuremberg 20
Stockholm 20
Augusta 19
Chicago 19
Frankfurt am Main 19
Boston 18
Hefei 18
Poplar 18
Haiphong 16
London 16
Brussels 15
Chennai 15
Milan 15
San Francisco 15
Cornaredo 14
Da Nang 14
Grevenbroich 14
Mexico City 14
Changsha 13
Seattle 13
Cairo 12
Central 12
Manchester 12
New Delhi 12
Amsterdam 11
Mumbai 11
Phoenix 11
Turku 11
Atlanta 10
Ica 10
Nairobi 10
Orange 10
Querétaro 10
San Buono 10
Tashkent 10
Brno 9
Hillsboro 9
Hải Dương 9
Lima 9
Ascoli Piceno 8
Totale 8.014
Nome #
Sistema di rilascio della lipossina A4 mediante membrana polimerica porosa ottenuta con elettrofilatura 348
Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles 207
Impiego di cellule staminali da legamento parodontale per lo screening farmacologico in fibrosi cistica. 204
Establishment and long-term culture of human cystic fibrosis endothelial cells 195
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 195
Wnt Signaling Behaves as a "Master Regulator" in the Osteogenic and Adipogenic Commitment of Human Amniotic Fluid Mesenchymal Stem Cells 193
Molecular and phenotypic characterization of human amniotic fluid-derived cells: A morphological and proteomic approach 192
ASSOCIATION OF LEPTIN, ENDOTHELIAL PERTURBATION AND COAGULATIVE ACTIVATION IN OBESE HEALTHY WOMEN (XVI National Congress of the Italian Society for the study of Arteriosclerosis - Chieti, 27-30 novembre 2002) 191
Mechanisms of endothelial cell dysfunction in cystic fibrosis 182
Pentraxin 3 and platelet activation in obese patients after gastric banding 179
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 172
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 171
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins 165
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 160
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 158
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 156
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 154
5-Lipoxygenase regulates malignant mesothelial cellsurvival: involvement of vascular endothelialgrowth factor 153
Immobilization and delivery of biologically active Lipoxin A4 using electrospinning technology 152
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. 151
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 149
Microvascular and Macrovascular Endothelial Cell Isolation and Purification from Lung-Derived Samples 148
Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity 148
Activation of human monocytes and the acute monocytic cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 and lipoxin B4: evidence for differential Ca2+ mobilization 145
Association of Inflammation Markers with ImpairedInsulin Sensitivity and Coagulative Activation inObese Healthy Women 144
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 142
3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics 141
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 141
Epigenetic regulation of the formyl peptide receptor 2 gene 141
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 141
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 138
Increased soluble CD40L levels in cystic fibrosis 137
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels 136
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 136
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 136
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 135
Lipoxins, resolvins, and the resolution of inflammation 134
Lipoxin receptors 132
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 132
Leptin increase is associated with markers of the hemostatic system in obese healthy women 130
Endothelial Perturbation in Children andAdolescents With Type 1 Diabetes: association with markers of the inflammatory reaction 130
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation 130
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 129
Diabetes mellitus during pregnancy interferes with the biological characteristics of wharton's jelly mesenchymal stem cells 128
Physical exercise increases urinary excretion of lipoxin A4 and related compounds 127
Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen 127
Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins 127
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors 126
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 126
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 125
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. 122
Homocysteine modulates the CD40/CD40L system 121
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 121
CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells 119
Lipoxin and aspirin-triggered lipoxins 114
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 114
Transcellular regulation of eicosanoids biosyntesis 113
Increased levels of soluble P-selectin in hypercholesterolemic patients 113
Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders 111
Aspirin-triggered 15-epi-lipoxin A4 biosynthesis in rat liver cells 111
Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review 111
PRORESOLVING AND ANTIMICROBIAL BIOACTIONS OF MELANOCORTINS ON CF CELLS 110
Methionine aminopeptidase-2 regulates human mesothelioma cell survival - Role of bcl-2 expression and telomerase activity 110
G972R IRS-1 variant impairs insulin regulation of eNOS in cultured human endothelial cells 109
5-Lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking 108
A Systematic Review on Organ-on-a-Chip in PDMS or Hydrogel in Dentistry: An Update of the Literature 107
Hepatocytes are a rich source of novel aspirin-trigged 15-epi-lipoxin A(4) 106
Cyclooxygenase-2-derived lipoxin A(4) increases gastric resistance to aspirin-induced damage 105
The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R 104
Peptido-leukotrienes stimulate von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells 102
Ligand bias and its association with pro-resolving actions of melanocortin drugs 102
Induction of functional Lipoxin A4 receptors in HL-60 cells 101
Ultrarush venom immunotherapy and the lipoxin a4 inflammation resolution pathway 101
Cyclooxygenase-2 and 5-Lipoxygenase converging functions on cell proliferation and tumor angiogenesis: Implications for cancer therapy 100
Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip: Cystic fibrosis airway chip 100
Proteomics investigation of human platelets in healthy donors and cystic fibrosis patients by shotgun nUPLC-MSE and 2DE: a comparative study 99
Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipoxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin 99
The Resolution Approach to Cystic Fibrosis Inflammation 99
Interaction of endotoxic lipid A and lipid X with purified human platelet protein kinase C 98
Human alveolar macrophages generate 15-HETE and can produce lipoxins 98
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide 97
Proteomics investigation of human platelets by shotgun nUPLC-MSE and 2DE experimental strategies: a comparative study 97
Lipoxin synthase activity of human platelet 12-Lipoxygenase 96
Lipoxin biosynthesis and actions: role of the human platelet LX-Synthase 96
Inflammation resolution: does the bone marrow have a say? 96
Lipoxin generation by human magakaryocyte-induced 12-lipoxygenase 95
Myelofibrosis: A role for Platelet Derived Growth Factor (PDGF) ? 95
Gene Expression of the D-Series Resolvin Pathway Predicts Activation of Anti-Tumor Immunity and Clinical Outcomes in Head and Neck Cancer 95
Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer 94
Reduced platelet mitogenic activity in myeloproliferative disorders 94
Increased circulating Interleukin-18 levels in centenarians with no signs of vascular disease: Another paradox of longevity? 93
Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins 91
Lipoxin and leukotriene production during receptor-activated interactions between human platelets and cytokine-primed neutrophils 91
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 90
PROTECTIVE ROLE OF RVD1 AND ITS RECEPTOR IN CYSTIC FIBROSIS 90
Fluticasone propionate reduces serum interleukin 8 in asthmatic patients 84
Endothelial perturbation in cystic fibrosis. 84
Endotoxic Lipid A induces intracellular Ca2+ increase in human platelets 83
Lipoxin generation by permeabilized human platelets 82
Loss of CFTR Reverses Senescence Hallmarks in SARS-CoV-2 Infected Bronchial Epithelial Cells 81
Totale 12.791
Categoria #
all - tutte 51.283
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.283


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021178 0 0 0 0 0 0 0 0 0 104 28 46
2021/2022600 9 14 4 145 26 16 10 39 38 39 81 179
2022/20231.804 130 246 111 213 183 327 86 144 234 26 50 54
2023/20241.011 78 46 49 30 57 294 185 51 19 46 22 134
2024/20252.229 130 381 319 83 81 97 78 118 246 92 267 337
2025/20264.108 321 211 461 560 462 265 763 283 453 329 0 0
Totale 13.606